Laboratory for Advanced Medicine (now Helio Genomics) raised $86 million to develop its liver cancer blood test; CEO Kenneth Chahine discussed it on Cheddar.
Featured on Cheddar.
The Laboratory for Advanced Medicine — the company that would become Helio Genomics — raised $86 million to further develop its blood test that can detect liver cancer. CEO Kenneth Chahine joined Cheddar to discuss the raise and the company’s methylation-based approach to early cancer detection.
The full interview aired on Cheddar.
Source: Cheddar.